Diabetic Macular Edema News and Research

RSS
Fluid can leak into the center of the macula, the part of the eye where sharp, straight-ahead vision occurs. The fluid makes the macula swell, blurring vision. This condition is called macular edema. It can occur at any stage of diabetic retinopathy, although it is more likely to occur as the disease progresses. About half of the people with proliferative retinopathy also have macular edema.
IRIDEX announces data from MicroPulse laser therapy study on DME

IRIDEX announces data from MicroPulse laser therapy study on DME

Akebia commences dosing in AKB-9778 Phase 1 study for diabetic macular edema and retinopathy

Akebia commences dosing in AKB-9778 Phase 1 study for diabetic macular edema and retinopathy

Mesoblast cleared to begin first phase 2 clinical trial for wet AMD

Mesoblast cleared to begin first phase 2 clinical trial for wet AMD

Mesoblast receives Singapore HSA regulatory clearance to begin wet AMD Phase 2 trial

Mesoblast receives Singapore HSA regulatory clearance to begin wet AMD Phase 2 trial

JDRF, iCo Therapeutics collaborate for iCo-007 Phase 2 trial in DME

JDRF, iCo Therapeutics collaborate for iCo-007 Phase 2 trial in DME

SARcode Bioscience initiates enrollment in SAR 1118 Phase 3 study for dry eye disease

SARcode Bioscience initiates enrollment in SAR 1118 Phase 3 study for dry eye disease

Lucentis receives Health Canada approval to treat vision loss from DME

Lucentis receives Health Canada approval to treat vision loss from DME

KalVista raises £8 million in series A round of funding

KalVista raises £8 million in series A round of funding

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

HSS, pSivida enter orthopedic evaluation agreement

HSS, pSivida enter orthopedic evaluation agreement

Sofinnova Ventures leads $44 million Series B private equity financing for SARcode Bioscience

Sofinnova Ventures leads $44 million Series B private equity financing for SARcode Bioscience

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD

Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD

NASDAQ halts Regeneron's common stock

NASDAQ halts Regeneron's common stock

PDL revises revenue guidance for second quarter 2011 to $122M

PDL revises revenue guidance for second quarter 2011 to $122M

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

Ampio's common stock to be listed on NASDAQ Capital Market

Ampio's common stock to be listed on NASDAQ Capital Market

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

Study demonstrates value of MicroPulse technology for diabetic macular edema treatment

Study demonstrates value of MicroPulse technology for diabetic macular edema treatment